Adjuvant treatment of mediastinitis with immunoglobins (Pentaglobin) after cardiac surgery (ATMI): study protocol.
D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D003131:Combined Modality Therapy; D004282:Documentation; D004311:Double-Blind Method; D006760:Hospitalization; D006801:Humans; D007070:Immunoglobulin A / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007075:Immunoglobulin M / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007902:Length of Stay; D008480:Mediastinitis / Q000276:immunology / Q000628:therapy*; D018579:Patient Selection; D010919:Placebos; D011446:Prospective Studies; D011786:Quality Control; D012107:Research Design; D018401:Sample Size; D013249:Sternum / Q000601:surgery; D013530:Surgical Wound Infection / Q000276:immunology / Q000628:therapy; D016896:Treatment Outcome
D007070:Immunoglobulin A; D007075:Immunoglobulin M; D016756:Immunoglobulins, Intravenous; D010919:Placebos; C060166:pentaglobulin